Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hentig

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Pharmaceutical Research|January 29, 2014
Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjectsLisa Felden, Carmen Walter, Carlo Angioni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2007
Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitorD Klarmann, I Martinez Saguer, M B Funk, et al.
European Journal of Medical Research|July 6, 2006
Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adultsNils von Hentig, A Müller, C Rottmann, et al.
International Journal of STD & AIDS|March 3, 2007
Dose reduction effective in alleviating symptoms of saquinavir toxicityC Stephan, A Carlebach, C Rottmann, et al.
Biomedicines|August 27, 2021
Zebrafish Blunt-Force TBI Induces Heterogenous Injury Pathologies That Mimic Human TBI and Responds with Sonic Hedgehog-Dependent Cell Proliferation across the NeuroaxisJames Hentig, Kaylee Cloghessy, Manuela Lahne, et al.
European Journal of Clinical Pharmacology|December 25, 2009
Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy settingAnnette Haberl, Manfred Moesch, Gabriele Nisius, et al.
HIV/AIDS (Auckland, N.Z.)|August 16, 2021
Evaluation of Platelet Activation by HIV Protease Inhibitors - The HIV-PLA II StudyGerrit Kann, Junaid Owasil, Karina Kuczka, et al.
Pharmacogenetics and Genomics|June 11, 2009
Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centersJörn Lötsch, Nils von Hentig, Rainer Freynhagen, et al.
Journal of Clinical Medicine|June 10, 2022
The Non-Concordance of Self-Reported and Performance-Based Measures of Vestibular Dysfunction in Military and Civilian Populations Following TBINicholas I Wood, James Hentig, Madison Hager, et al.
Thrombosis and Haemostasis|June 4, 2004
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting TimeSebastian Harder, Jochen Graff, Ute Klinkhardt, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Pharmaceutical Research|January 29, 2014
Similar maximum systemic but not local cyclooxygenase-2 inhibition by 50 mg lumiracoxib and 90 mg etoricoxib: a randomized controlled trial in healthy subjectsLisa Felden, Carmen Walter, Carlo Angioni, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 18, 2007
Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitorD Klarmann, I Martinez Saguer, M B Funk, et al.
European Journal of Medical Research|July 6, 2006
Pharmacokinetics and tolerability of a combination of indinavir, lopinavir and ritonavir in multiply pretreated HIV-1 infected adultsNils von Hentig, A Müller, C Rottmann, et al.
International Journal of STD & AIDS|March 3, 2007
Dose reduction effective in alleviating symptoms of saquinavir toxicityC Stephan, A Carlebach, C Rottmann, et al.
Biomedicines|August 27, 2021
Zebrafish Blunt-Force TBI Induces Heterogenous Injury Pathologies That Mimic Human TBI and Responds with Sonic Hedgehog-Dependent Cell Proliferation across the NeuroaxisJames Hentig, Kaylee Cloghessy, Manuela Lahne, et al.
European Journal of Clinical Pharmacology|December 25, 2009
Atazanavir plasma concentrations are impaired in HIV-1-infected adults simultaneously taking a methadone oral solution in a once-daily observed therapy settingAnnette Haberl, Manfred Moesch, Gabriele Nisius, et al.
HIV/AIDS (Auckland, N.Z.)|August 16, 2021
Evaluation of Platelet Activation by HIV Protease Inhibitors - The HIV-PLA II StudyGerrit Kann, Junaid Owasil, Karina Kuczka, et al.
Pharmacogenetics and Genomics|June 11, 2009
Cross-sectional analysis of the influence of currently known pharmacogenetic modulators on opioid therapy in outpatient pain centersJörn Lötsch, Nils von Hentig, Rainer Freynhagen, et al.
Journal of Clinical Medicine|June 10, 2022
The Non-Concordance of Self-Reported and Performance-Based Measures of Vestibular Dysfunction in Military and Civilian Populations Following TBINicholas I Wood, James Hentig, Madison Hager, et al.
Thrombosis and Haemostasis|June 4, 2004
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting TimeSebastian Harder, Jochen Graff, Ute Klinkhardt, et al.
Pageof 6